
- Volume 0 0
Electronic Rx-Monitoring Bill Will Reach Congress in 2005
New federal legislation being draftedfor consideration by the new Congresswill require all states to develophigh-tech prescription-drug monitoringsystems patterned after Kentucky'sAll Schedule Prescription ElectronicReporting (KASPER) program.
The bill, which is the brainchild ofRep Edward Whitfield (R, KY), will bedesigned to curb prescription drugabuse by electronically alerting physicianswhenever one of their patientsattempts to fill a prescription for aSchedule II to IV controlled substanceat any pharmacy in the nation. Inaddition to Kentucky, several otherstates already have such systems inplace, but they report only onintrastate dispensing activities.
As well as serving as a tool for lawenforcement, a nationwide Rx-monitoringprogram would be an importantnew "source of information for physiciansand pharmacists" throughout thecountry, Sen Whitfield told Congress.The key to the success of such a programwill be to curb clearly illicit drugdiversion without discouraging physiciansfrom prescribing controlled substancesto the patients who need them,he said.
"The last thing we want to do isscare doctors and patients and createa situation where physicians areundertreating pain for fear of beingarrested, and patients are underreportingpain out of the same fear,"the senator said.
Articles in this issue
almost 21 years ago
Treatment of Patients with Atrial Fibrillationalmost 21 years ago
Understanding and Managing Polypharmacy in the Elderlyalmost 21 years ago
Counterfeit Drugs: A Real Cause for Alarmalmost 21 years ago
New Treatments on the Way for Diabetes-Part 1almost 21 years ago
Effective Counseling for Patients with Hypertensionalmost 21 years ago
Preventing and Managing Thrombosis with Anticoagulantsalmost 21 years ago
RxPRODUCT NEWS: PROFILE: Cardizem LA (diltiazem hydrochloride)almost 21 years ago
Staying Well with Herbs and Vitaminsalmost 21 years ago
Health Professional Imposters-Part 1Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.